Simpler Grants.gov #PAR-25-322

NIH Stephen I. Katz Early Stage Investigator Research Project Grant (R01 Clinical Trial Not Allowed)

The National Institutes of Health (NIH) is seeking applications for the Stephen I. Katz Early Stage Investigator Research Project Grant, aimed at supporting innovative research projects for early stage investigators (ESIs) who are pursuing a new research direction without preliminary data. - Government Buyer: - National Institutes of Health (NIH) - OEMs and Vendors: - No specific OEMs or vendors are mentioned, as this is a research grant opportunity, not a procurement of products. - Products/Services Requested: - Research Project Grant (R01) for Early Stage Investigators - Supports innovative research projects representing a change in research direction - No preliminary data allowed in applications - Requires a separate attachment describing the change in research direction - Open to a wide range of eligible applicants: government entities, businesses, educational institutions, nonprofits, and other organizations - Unique or Notable Requirements: - Applications must not include preliminary data - Applicants must submit a separate attachment describing the change in research direction - Foreign organizations and non-domestic components are not eligible - No cost sharing or matching is required - Covers multiple health-related research areas (e.g., cardiovascular diseases, cancer, vision, diabetes, sleep disorders, mental health, environmental health) - Funding instrument is a discretionary grant

Description

The Stephen I. Katz Early Stage Investigator Research Project Grant supports an innovative project that represents a change in research direction for an early stage investigator (ESI) and for which no preliminary data exist. Applications must not include preliminary data and must include a separate attachment describing the change in research direction. The grant is intended for a variety of eligible applicants including government entities, businesses, educational institutions, nonprofits, and other organizations. The funding instrument type is a grant and the opportunity is discretionary with a closing date of August 25, 2028.

View original listing